Skip to Main Content

Author Details

Lakhmir S Chawla
Veterans Affairs Medical Center San Diego
2001
176
49
PMIDPaper TitleJournal TitlePublished Year
36750878Rationale for sequential extracorporeal therapy (SET) in sepsis.Crit Care2023
38017578External validation of the modified sepsis renal angina index for prediction of severe acute kidney injury in children with septic shock.Crit Care2023
38073554Anticoagulation practices for continuous renal replacement therapy: a survey of physicians from the United States.Ren Fail2023
37348482Adsorption of Pathogens and Blockade of Sepsis Cascade.Contrib Nephrol2023
36988335Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients.Crit Care Med2023
35171852The Association Between Angiotensin II and Renin Kinetics in Patients After Cardiac Surgery.Anesth Analg2022
35583867Utility of Biomarkers for Sepsis-Associated Acute Kidney Injury Staging.JAMA Netw Open2022
35696851Characterising acute kidney injury: The complementary roles of biomarkers of renal stress and renal function.J Crit Care2022
35484549Permissive azotemia during acute kidney injury enables more rapid renal recovery and less renal fibrosis: a hypothesis and clinical development plan.Crit Care2022
35967111Integration of the Renal Angina Index and Urine Neutrophil Gelatinase-Associated Lipocalin Improves Severe Acute Kidney Injury Prediction in Critically Ill Children and Young Adults.Kidney Int Rep2022
36018286VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK.Shock2022
35919538Performance of a Standardized Clinical Assay for Urinary C-C Motif Chemokine Ligand 14 (CCL14) for Persistent Severe Acute Kidney Injury.Kidney3602022
33320784Kinetic Changes of Plasma Renin Concentrations Predict Acute Kidney Injury in Cardiac Surgery Patients.Am J Respir Crit Care Med2021
33566467Use of Biomarkers to Identify Acute Kidney Injury to Help Detect Sepsis in Patients With Infection.Crit Care Med2021
33752866Acute Kidney Disease to Chronic Kidney Disease.Crit Care Clin2021
34775967Why the renin-angiotensin-aldosterone system (RAAS) in critically ill patients can no longer be ignored.Crit Care2021
34059102External validation of urinary C-C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury.Crit Care2021
34307980Recalibration of the Renal Angina Index for Pediatric Septic Shock.Kidney Int Rep2021
33971784The furosemide stress test: current use and future potential.Ren Fail2021
32143585Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease.BMC Nephrol2020
35369555Single Lumen Alternating Micro-Batch Hemodiafiltration (SLAMB-HDF): A Device for Minimally Invasive Renal Replacement Therapy.Kidney3602020
32028998Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock.Crit Care2020
32940241Nephrologist Follow-Up Care of Patients With Acute Kidney Disease Improves Outcomes: Taiwan Experience.Value Health2020
32154193Opportunities and Barriers to Innovation in Acute Care Pediatrics.Front Pediatr2020
30616731Response.Chest2019
31343478Use of Cell Cycle Arrest Biomarkers in Conjunction With Classical Markers of Acute Kidney Injury.Crit Care Med2019
31618746Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness.Cardiorenal Med2019
30768522The authors reply.Crit Care Med2019
31035185The furosemide stress test for prediction of worsening acute kidney injury in critically ill patients: A multicenter, prospective, observational study.J Crit Care2019
30784615Therapeutic Opportunities for Hepcidin in Acute Care Medicine.Crit Care Clin2019
31161442Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial.Ann Intensive Care2019
30992045Broad spectrum vasopressors: a new approach to the initial management of septic shock?Crit Care2019
29189343Kinetics of Urinary Cell Cycle Arrest Markers for Acute Kidney Injury Following Exposure to Potential Renal Insults.Crit Care Med2018
30135570Global epidemiology and outcomes of acute kidney injury.Nat Rev Nephrol2018
30368243Angiotensin converting enzyme defects in shock: implications for future therapy.Crit Care2018
29529338Pre-operative anaemia, intra-operative hepcidin concentration and acute kidney injury after cardiac surgery: a retrospective observational study.Anaesthesia2018
29393153Acute Kidney Injury Recovery.Contrib Nephrol2018
29523680Overcoming Translational Barriers in Acute Kidney Injury: A Report from an NIDDK Workshop.Clin J Am Soc Nephrol2018
29509568Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.Crit Care Med2018
29034718The prognostic value of the furosemide stress test in predicting delayed graft function following deceased donor kidney transplantation.Biomarkers2018
29329694Management of Refractory Vasodilatory Shock.Chest2018
29023830Drug management in acute kidney disease - Report of the Acute Disease Quality Initiative XVI meeting.Br J Clin Pharmacol2018
27522513The Effect of Spironolactone on Acute Kidney Injury After Cardiac Surgery: A Randomized, Placebo-Controlled Trial.Am J Kidney Dis2017
28489648Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety.Crit Care Med2017
28337509Understanding renal recovery.Intensive Care Med2017
28215131Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3): protocol for a phase III, double-blind, randomised controlled trial.Crit Care Resusc2017
28291091Impact of Acute Kidney Injury in Patients Hospitalized With Pneumonia.Crit Care Med2017
28239173Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup.Nat Rev Nephrol2017
28145850Characterization of end-of-life electroencephalographic surges in critically ill patients.Death Stud2017
29248147Sequelae of AKI.Best Pract Res Clin Anaesthesiol2017
  • 1 - 50 of 176

Recommended Authors

Yale School of Medicine
Career Start Year 2013
Number of shared co-authors 11
UPMC Children's Hospital of Pittsburgh
Career Start Year 2013
Number of shared co-authors 14
Clinical Sciences Research and Development
Career Start Year 2010
Number of shared co-authors 1
King's College London, Guy's & St. Thomas' Hospital
Career Start Year 2009
Number of shared co-authors 25
Cincinnati Children's Hospital Medical Center
Career Start Year 2009
Number of shared co-authors 15
University of Florence
Career Start Year 2009
Number of shared co-authors 30
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2008
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 2008
Number of shared co-authors 6
University of Milano-Bicocca
Career Start Year 2007
Number of shared co-authors 13
Uppsala University
Career Start Year 2006
Number of shared co-authors 0
Zhongnan Hospital of Wuhan University
Career Start Year 2006
Number of shared co-authors 31
Chulalongkorn University
Career Start Year 2006
Number of shared co-authors 35
Johns Hopkins University
Career Start Year 2005
Number of shared co-authors 16
University of California san francisco
Career Start Year 2005
Number of shared co-authors 42
University of Dundee
Career Start Year 2004
Number of shared co-authors 30
University of Florida
Career Start Year 2003
Number of shared co-authors 10
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2002
Number of shared co-authors 5
Health Services Research and Development
Career Start Year 2001
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 5
Apollo Hospitals
Career Start Year 2000
Number of shared co-authors 9
Montefiore Medical Center and Albert Einstein College of Medicine
Career Start Year 1999
Number of shared co-authors 10
INSERM U8, Universite Paris Saclay
Career Start Year 1999
Number of shared co-authors 1
LSU Health New Orleans School of Medicine
Career Start Year 1999
Number of shared co-authors 2
International Renal Research Institute of Vicenza (IRRIV)
Career Start Year 1997
Number of shared co-authors 42
Hospital Obrero No 2-CNS
Career Start Year 1995
Number of shared co-authors 20
University of Maryland School of Medicine
Career Start Year 1994
Number of shared co-authors 3
Kidney Research Institute and Division of Nephrology, University of Washington
Career Start Year 1990
Number of shared co-authors 21
Christchurch Hospital, University of Otago Christchurch
Career Start Year 1989
Number of shared co-authors 8
The PACES Center for Value in Healthcare
Career Start Year 1985
Number of shared co-authors 25
Clinical and Translational Research Accelerator, Yale University School of Medicine
Career Start Year 1949
Number of shared co-authors 25

Collaborators

Spectral Medical Inc.
Co-authored papers 46
Cincinnati Children's Hospital Medical Center, University of Cincinnati
Co-authored papers 20
International Renal Research Institute of Vicenza (IRRIV)
Co-authored papers 20
Cleveland Clinic
Co-authored papers 19
University of Chicago, Pritzker School of Medicine
Co-authored papers 18
Emory University
Co-authored papers 15
University of Alberta and Alberta Health Services
Co-authored papers 14
George Washington University School of Medicine and Health Sciences
Co-authored papers 14
Co-authored papers 13
Truth for Health Foundation
Co-authored papers 12
Royal Surrey Hospital Foundation Trust
Co-authored papers 12
University of California San Diego
Co-authored papers 12
Mayo Clinic Rochester
Co-authored papers 12
King's College London, Guy's & St Thomas' Hospital
Co-authored papers 11
University of Wisconsin School of Medicine and Public Health
Co-authored papers 10
University College Dublin
Co-authored papers 10
University of Pittsburgh School of Medicine
Co-authored papers 9
University of Florida, Univerzitet u Sarajevu Medicinski Fakultet
Co-authored papers 9
La Jolla Pharmaceutical Company
Co-authored papers 9
Ann & Robert Lurie Children's Hospital of Chicago, Northwestern University
Co-authored papers 8
University of California san francisco
Co-authored papers 8
Ghent University Hospital, and Research Foundation Flanders (FWO), Ghent University
Co-authored papers 8
Royal Melbourne Hospital
Co-authored papers 8
University Hospital Munster
Co-authored papers 7
Division of Nephrology and Center for Immunity, University of Virginia
Co-authored papers 7
4University of California San Diego
Co-authored papers 6
Otto-von-Guericke University Magdeburg
Co-authored papers 6
University of Toronto
Co-authored papers 6
University of Michigan Medical Center ann arbor
Co-authored papers 5
University of Colorado School of Medicine
Co-authored papers 5